Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.51%GBPTRY+0.41%AUDCHF+0.41%USDCAD-0.40%NZDCHF+0.39%EURCAD-0.34%GBPHKD+0.32%GBPUSD+0.31%CADJPY+0.29%GBPMXN-0.28%CHFJPY-0.28%USDTRY+0.28%EURCHF+0.26%AUDSGD+0.25%NZDSGD+0.24%NZDUSD+0.23%USDNOK-0.22%EURGBP-0.21%AUDUSD+0.21%NZDCAD-0.21%GBPJPY+0.20%USDCHF+0.19%GBPSGD+0.19%AUDCAD-0.19%USDZAR-0.18%NZDMXN+0.17%USDSEK-0.17%USDPLN-0.17%EURSGD+0.16%USDILS+0.16%CHFSGD+0.15%SGDJPY-0.15%EURHKD+0.12%USDDKK-0.12%EURAUD-0.11%NZDJPY+0.11%GBPAUD+0.11%AUDJPY+0.11%CHFNOK-0.11%NOKJPY+0.11%EURNZD-0.10%EURNOK-0.10%USDJPY-0.10%EURCNH+0.09%AUDDKK+0.09%EURUSD+0.08%GBPCAD-0.08%GBPNZD+0.08%CHFSEK-0.06%PLNJPY+0.06%USDTHB+0.06%EURZAR-0.05%EURSEK-0.05%EURPLN-0.05%USDSGD+0.05%USDCOP-0.04%GBPZAR-0.03%USDMXN-0.03%USDCNH-0.03%EURCZK+0.01%EURJPY-0.01%AUDNZD+0.01%AUDNOK-0.01%USDHKD+0.01%EURDKK0.00%COTTON+0.97%HG1+0.72%XNGUSD+0.44%S1+0.37%W1-0.28%UKOIL-0.28%USOIL-0.22%XPTUSD-0.15%XAGUSD-0.06%GAGUSD-0.06%C1-0.05%GAUUSD-0.04%BTCUSD+2.39%ETHUSD+17.67%USDTUSD+0.01%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.80%ZECUSDT+8.47%DOGEUSD+14.12%XMRUSDT+5.42%LINKUSD+13.42%XLMUSD-0.06%BCHUSDT+5.33%UNIUSD+7.42%LTCUSD+9.66%SUIUSD+3.23%HBARUSDT+0.18%TONUSD+26.15%TAOUSDT+3.38%AAVEUSD+3.30%DOTUSDT-0.45%ICPUSDT+0.17%ONDOUSDT+0.19%WLDUSDT-0.60%ARBUSDT+6.37%JUPUSDT+0.62%ATOMUSDT+1.29%INJUSDT+13.43%STXUSDT+6.52%FETUSDT+2.08%TIAUSDT+8.81%PYTHUSDT+0.62%SEIUSDT+4.57%IMXUSDT+0.06%OPUSDT+19.70%GRTUSDT+3.86%IOTAUSDT+0.60%WIFUSDT+2.21%AXSUSDT-1.66%POLUSDT+2.60%FARTCOINUSDT+0.63%EOSUSDT+1.66%DYDXUSDT+3.87%GALAUSDT-1.87%ORDIUSDT-0.21%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.51%GBPTRY+0.41%AUDCHF+0.41%USDCAD-0.40%NZDCHF+0.39%EURCAD-0.34%GBPHKD+0.32%GBPUSD+0.31%CADJPY+0.29%GBPMXN-0.28%CHFJPY-0.28%USDTRY+0.28%EURCHF+0.26%AUDSGD+0.25%NZDSGD+0.24%NZDUSD+0.23%USDNOK-0.22%EURGBP-0.21%AUDUSD+0.21%NZDCAD-0.21%GBPJPY+0.20%USDCHF+0.19%GBPSGD+0.19%AUDCAD-0.19%USDZAR-0.18%NZDMXN+0.17%USDSEK-0.17%USDPLN-0.17%EURSGD+0.16%USDILS+0.16%CHFSGD+0.15%SGDJPY-0.15%EURHKD+0.12%USDDKK-0.12%EURAUD-0.11%NZDJPY+0.11%GBPAUD+0.11%AUDJPY+0.11%CHFNOK-0.11%NOKJPY+0.11%EURNZD-0.10%EURNOK-0.10%USDJPY-0.10%EURCNH+0.09%AUDDKK+0.09%EURUSD+0.08%GBPCAD-0.08%GBPNZD+0.08%CHFSEK-0.06%PLNJPY+0.06%USDTHB+0.06%EURZAR-0.05%EURSEK-0.05%EURPLN-0.05%USDSGD+0.05%USDCOP-0.04%GBPZAR-0.03%USDMXN-0.03%USDCNH-0.03%EURCZK+0.01%EURJPY-0.01%AUDNZD+0.01%AUDNOK-0.01%USDHKD+0.01%EURDKK0.00%COTTON+0.97%HG1+0.72%XNGUSD+0.44%S1+0.37%W1-0.28%UKOIL-0.28%USOIL-0.22%XPTUSD-0.15%XAGUSD-0.06%GAGUSD-0.06%C1-0.05%GAUUSD-0.04%BTCUSD+2.39%ETHUSD+17.67%USDTUSD+0.01%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.80%ZECUSDT+8.47%DOGEUSD+14.12%XMRUSDT+5.42%LINKUSD+13.42%XLMUSD-0.06%BCHUSDT+5.33%UNIUSD+7.42%LTCUSD+9.66%SUIUSD+3.23%HBARUSDT+0.18%TONUSD+26.15%TAOUSDT+3.38%AAVEUSD+3.30%DOTUSDT-0.45%ICPUSDT+0.17%ONDOUSDT+0.19%WLDUSDT-0.60%ARBUSDT+6.37%JUPUSDT+0.62%ATOMUSDT+1.29%INJUSDT+13.43%STXUSDT+6.52%FETUSDT+2.08%TIAUSDT+8.81%PYTHUSDT+0.62%SEIUSDT+4.57%IMXUSDT+0.06%OPUSDT+19.70%GRTUSDT+3.86%IOTAUSDT+0.60%WIFUSDT+2.21%AXSUSDT-1.66%POLUSDT+2.60%FARTCOINUSDT+0.63%EOSUSDT+1.66%DYDXUSDT+3.87%GALAUSDT-1.87%ORDIUSDT-0.21%RONINUSDT-3.42%NOTUSDT+1.21%
TT

Tango Therapeutics, Inc. (TNGX)

NASDAQ • Healthcare

$22.22
-$1.95 (-8.1%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$23.85
Day Range$21.85 - $24.11
Avg. Volume (3M)3.8M
Market Cap$3.6B
52 Week Range
$6.69$34.39
Next EarningsIn 20 daysNov 3, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$53.8M
Net Income (TTM)
-$123.7M
EPS (TTM)
-$0.85
ROA (TTM)
-11.52%
Current Ratio
50.82

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+6.5%Q1 2026-$0.29
-2.0%Q2 2026-$0.32
-16.6%Q3 2026-$0.37
Next

Nov 3

in 20 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -16.6%

Tango Therapeutics’ preliminary results for the second fiscal quarter of 2026, reported August 10, showed a wider loss and EPS that trailed consensus, with EPS of $-0.37 trailing the $-0.32 estimate (-17%) and down from $-0.35 a year ago. Net income was a loss of roughly $55.3 million, down 42.4% year over year from a loss of about $38.9 million, alongside an operating loss of about $59.8 million. The company generated negative operating cash flow of roughly $38.9 million in the quarter. For the next period, consensus calls for EPS of $-0.34 on revenue of $3.3 million.

Next report — what to expect

Tango Therapeutics, Inc. (TNGX) reports on November 3, 2026. Wall Street is looking for consensus EPS of -$0.34 on revenue of $3.3 million. For trailing context, revenue was -100.0% year over year last quarter. The company has beaten EPS in 3 of 8 most recent quarters.

View full earnings history

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing precision cancer medicines around defined genetic vulnerabilities. Trading as TNGX, it focuses on oncology drug candidates for tumor types selected by specific mutations and alterations, and it operates as a small-cap therapeutic developer in the healthcare sector.

Name
Tango Therapeutics, Inc.
CEO
Malte Peters
Website
www.tangotx.com
Industry
Healthcare
Year Founded
2017
Employees
137

Today's Snapshot

AI-generated

TNGX closed 8.1% below yesterday's close, in line with a weaker sector. Trading was busier than usual, with volume roughly twice its usual level. JPMorgan, an investment bank, reiterated its rating on Tango Therapeutics ahead of new cancer-drug data.

Trading Volume

Above 10d avg 4.2M

9.6M

vs S&P 500 Today

Strong Underperformance

-8.05%

Updated: October 13, 2026 at 20:26 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
TNGX signals a sell bias with a cluster of bearish short- and medium-term moving averages despite being near the 200-day level. The price is 22.22 and sits only marginally above the 200-day around 21.45, while momentum and MACD readings are negative and OBV shows distribution. ADX near 12 indicates a weak trend, but ATR at about 7.13% flags elevated volatility that can exacerbate downside moves, and pivot levels are aligned with resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$20.18 - $24.28
    Sell
  • RSI (14)42.89
    Neutral
  • Stochastic %K (14, 3, 3)49.91
    Neutral
  • MACD Level (12, 26)-0.38
    Sell

Peers & Related Assets

RVMDRevolution Medicines, Inc.
$188.44-2.8%
ERASErasca, Inc.
$14.78-4.4%
RLAYRelay Therapeutics, Inc.
$17.36-3.5%
IDYAIDEAYA Biosciences, Inc.
$34.26-5.0%
NRIXNurix Therapeutics, Inc.
$22.13-0.1%
NUVBNuvation Bio Inc.
$4.72-3.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.